跳至主要内容
临床试验/JPRN-UMIN000028039
JPRN-UMIN000028039已完成未知

Comparison of Tolvaptan treatment and conventional treatment in elderly acute heart failure. - Comparison of Tolvaptan treatment and conventional treatment in elderly acute heart failure.

Iiyama redcross hospital0 个研究点目标入组 60 人开始时间: 2017年7月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
76years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Under 75 2.Hypersensitivity for Tolvaptan or Mozavaptan. 3.Anuria 4.Insensitivity to thurst of difficulty in water in take. 5.Patients who already have tolvaptan at entry. 6.Severe coronary arterydisease and cerebrovascular disease. 7.Severe renal failure 8.Hypernatremia(serum Na>146mEq/L)and(serum Na<125mEq/L). 9.Hyperkalemia(serum K>5.5mEq/L)and(serum K<3.0mEq/L). 10.Chronic hepatitis Liver dysfunction(pharmacological etc.). 11.Hepatic encephalopathy. 12.Any conditions inappropriate to this trial deemed by the investigator.

研究者

发起方
Iiyama redcross hospital

相似试验

Comparison of Tolvaptan treatment and conventional... | 临床试验